COVID-19 vaccines: challenges and promises of trials, manufacturing and allocation of doses-Reference-Cited by-同舟云学术

COVID-19 vaccines: challenges and promises of trials, manufacturing and allocation of doses

Published:2021-03 Issue:1 Volume:3 Page:
ISSN:2631-3316
Container-title:Future Drug Discovery
language:en
Short-container-title:Future Drug Discovery

Author:

Spadaro Benedetta¹^ORCID

Affiliation:

1. MPhil in Therapeutic Sciences, Cambridge Academy of Therapeutic Sciences, University of Cambridge, Cambridge CB2 1RX, UK

Abstract

Tweetable abstract Reflections on challenges and promises of COVID-19 vaccine development show opportunities for innovation and collaboration between stakeholders.

Publisher

Future Science Ltd

Link

https://www.future-science.com/doi/pdf/10.4155/fdd-2020-0031

Reference13 articles.

1. Risk in Vaccine Research and Development Quantified

2. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2

3. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2

4. Interpreting a covid-19 test result

5. World Health Organization. Fair allocation mechanism for COVID-19 vaccines through the COVAX Facility. (2020). www.who.int/publications/m/item/fair-allocation-mechanism-for-covid-19-vaccines-through-the-covax-facility

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pandemic-response adenoviral vector and RNA vaccine manufacturing;npj Vaccines;2022-03-02

2. Welcome to Volume 4 of Future Drug Discovery;Future Drug Discovery;2022-03

3. Pandemic-response adenoviral vector and RNA vaccine manufacturing;2021-09-02